General
Introduction
Methods
Results
Discussion
100

The last name of any author of this paper.

What is McIntyre, Zhang-James, or Kwan?

100

The phrase for which SMI is an acronym.

What is Severe Mental Illness?

100

The name of the research network from which the data in this study was abstracted.

What is TriNetX?

100

The two cohorts that were analyzed separately in terms of the results of this trial, reported on in Table 1.

What are the SMI cohort and the cohort without SMI?

100

The subclass of observational studies that best describes the research study design of this study. 

What is a cohort study/

200

Within 2 weeks, the date this paper was published on-line.

What is August 26, 2026?

200

The medical condition that is reported as the "predominant contributor" to premature mortality in patients with mental illnesses.

What is cardiovascular disease?

200

The full name or acronym of the medication class which served as the control or comparison medication intervention for subjects in this study.

What is SGLT2 or sodium-glucose-cotransporter 2?

200

The full names of the survival curves presented in Figure 2 to visually illustrate the results of the primary outcome, abbreviated commonly as K-M.

What are Kaplan-Meier survival curves?

200

Between "older" and "newer" medications in the GLP-1 RA class, the class that was associated with greater protective effects against the negative outcomes in this study.

What are "newer" GLP-1 RAs?

300

The copyright holder of this article.

What is the American Medical Association?

300

The complete phrase for which GLP-1 RA is an acronym for.

What is glucagon-like peptide-1 receptor agonist?

300

The generic name of any medication used in the control or comparison group intervention in this study.

What is empagliflozin, dapagliflozin, canagliflozin, or ertugliflozin?

300

The outcome identified as the Key Secondary Outcome in this study, which in general was similar to the results of the primary outcome.

What is 1 Year all-cause mortality?

300

The total number of subjects in the SMI cohort that were randomly assigned to SMI GLP-1 RA exposure, within 100,000.

What is zero?

400

The country that the corresponding author lists in his address.

What is Canada?

400

The authors report that there is good evidence that medication treatment can reduce this blood test indicator of diabetes severity significantly in as few as 26 weeks.

What is hemoglobin A1C?

400

The primary outcome defined for this study.

What is all-cause mortality at 4 years?

400

This particular medication was used in assessment of secondary outcomes in the study, separating it out from its general class.

What is semaglutide?

400

Any 1 of the 4 main strengths of the study listed in the discussion section by the authors.

What are: 1. trial emulation design; 2. large sample size; 3. incorporation of baseline demographic and cardiovascular codes into the propensity model; and 4. convergence of findings across time-to-event models.

500

Within 5, the number of references included in this manuscript.

What is 42?

500
Within 2%, the percentage of body weight reduction reported in 36 weeks in a clinical trial of semaglutide co-treatment with clozapine in adults with schizophrenia cited by the authors in the introduction.

What is 13.88%?

500

The study method that aimed to balance co-variates between the treatment cohorts that attempts to isolate the effect of the treatment variable in terms of assessing the primary outcome differences between the treatment groups.

What is propensity score matching?

500

This type of prespecified analysis was used to examine the effects of diabetes stratification, exclusion of baseline heart failure and kidney disease, and censoring at treatment crossover on the outcomes in the study.

What is sensitivity analysis?

500

The authors site the fact that results of the study were consistent across these three specific mental illness categories as evidence supporting generalizability of the results.

What are major depressive disorder, bipolar disorder, and schizophrenia?

M
e
n
u